Don't Jump to Combo Med Duzallo for Chronic Gout
Duzallo (doo-ZAL-oh) will be a new chronic gout med that combines lesinurad with allopurinol.
Reps will tout Duzallo as a combo that targets both causes of gout. Allopurinol decreases uric acid production...and lesinurad (Zurampic) increases renal uric acid excretion, similar to probenecid.
Duzallo helps about one more in 4 patients reach uric acid goals...compared to about 300 mg/day of allopurinol alone.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote